Leaflet: Information for the user
Zeninas film-coated tablets
Powder ofAloe ferox(Aloe)/Extract ofRhamnus purshianusD.C(Sacred Bark)
Read the entire leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the leaflet
Zeninas film-coated tablets are a stimulant laxative. The laxative effects are produced by an increase in colon movement and stimulation of fluid secretion processes, favoring the evacuation of feces.
Zeninas film-coated tablets are a plant-based medication for the treatment of occasional constipation.
You should consult a doctor if your condition worsens or does not improve after 4 days.
Do not take Zeninas film-coated tablets
Warnings and precautions
Consult your doctor or pharmacist before starting to take Zeninas film-coated tablets.
If this medication is administered to dependent patients, they should have frequent diaper changes to avoid prolonged contact with feces.
Use of other medications and Zeninas film-coated tablets
Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication, including those purchased without a prescription.
Patients undergoing treatment with cardiac glycosides, antiarrhythmics, medications that prolong the QT curve (quinidine), diuretics (medications that facilitate and increase urine elimination) or licorice root, antibiotics (used to treat infections), medications to treat stomach acidity (antacids) such as cimetidine, famotidine, and ranitidine, potassium supplements. Indomethacin, acetylsalicylic acid, and other prostaglandin synthesis inhibitors should consult their doctor before taking this medication.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
This preparation is eliminated in small amounts in breast milk, and although there are no data on the possible laxative effects it may have on infants, its use is not recommended in these circumstances.
Driving and using machines
No effects on the ability to drive or use machines have been described at the recommended doses.
Follow the administration instructions of the medication contained in this leaflet or as indicated by your doctor, pharmacist, or nurse. In case of doubt, ask your doctor or pharmacist.
The recommended dose is:
Adults and adolescents over 12 years:1 film-coated tablet per day.
Use in children
Do not use this medication in children under 12 years.
Use in people over 65 years
Older adults should not take this medication without consulting their doctor, as they are more likely to experience its side effects.
Method of administration
This medication is administered orally.
The Zeninas film-coated tablet is swallowed with a glass of water, preferably one hour after dinner and before bedtime; the laxative effect will generally be observed the next morning.
If constipation persists for more than 4 days, or if symptoms worsen or others appear, you should interrupt treatment and consult your doctor.
If you take more Zeninas film-coated tablets than you should
If you have taken more Zeninas film-coated tablets than you should, consult your doctor or pharmacist immediately. The main symptoms of overdose are: massive diarrhea with water and salt loss.
If it is severe, it can cause confusion, cardiac arrhythmia, cramps, fatigue, or weakness, which can be more pronounced in older people.
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
If you forget to take Zeninas film-coated tablets
Do not take a double dose to make up for forgotten doses.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone experiences them.
The side effects of the medication are mild and transient.
Digestive, gastrointestinal, abdominal pain, colic-type, belching, and intestinal cramps may appear. The urine may turn pink-yellow to brown, which is of no importance and is due to the elimination of the medication's components.
If you consider that any of the side effects you are experiencing is serious or if you notice any other side effect not mentioned in this leaflet, inform your doctor or pharmacist.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep out of sight and reach of children.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Do not use Zeninas film-coated tablets if you observe any signs of deterioration in the inner packaging that contains the film-coated tablets.
Medications should not be thrown down the drain or into the trash. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Zeninas film-coated tablets
Core: licorice, microcrystalline cellulose, sodium croscarmellose, colloidal silicon dioxide, magnesium stearate, and purified water.
Coating: Vivacoat PA, which contains hypromellose, polydextrose, talc, red iron oxide, black iron oxide, titanium dioxide, polyethylene glycol 3350, yellow iron oxide, and indigo dye.
Appearance of the product and package contents
Brown, round, and convex film-coated tablet.
It is presented in formats of 30 film-coated tablets packaged in PVC/PVDC/AL blister packs.
Marketing authorization holder
Vemedia Manufacturing B.V. Verrijn Stuartweg 60
NL-1112 AX Diemen
Netherlands
Local representative:
Vemedia Pharma Hispania S.A.
C/Aragón 182 5ª planta
08011 Barcelona
Spain
Manufacturer
Vemedia Manufacturing B.V. Verrijn Stuartweg 60
NL-1112 AX Diemen
Netherlands
Laboratorium Sanitatis, S.L.
Parque Tecnológico de Álava
Leonardo Da Vinci, 11
E-01510 Miñano – Araba / Álava (Spain)
This leaflet was approved in September 2020
Date of the last revision of this leaflet:
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/